Financials
Value Q2, 25Q3, 25 TTM Selling/general/admin expenses 21.32 K6.56 M — Research & development —— — Operating income -21.32 K4.18 M — Non-Operating Income, Total —926 K — Interest expense, net of interest capitalized —— — Non-Operating Income, excl. Interest Expenses —925 K — Unusual income/expense —1 000 — Pretax income -21.32 K5.11 M — Equity in earnings —— — Taxes —— — Non-controlling/minority interest —— — After tax other income/expense —— — Net income before discontinued operations -21.32 K3.25 M — Discontinued operations —— — Net income -21.32 K3.25 M — Dilution adjustment —— — Preferred dividends —— — Diluted net income available to common stockholders -21.32 K3.25 M — Basic earnings per share (Basic EPS) -21.32-0.12 — Diluted earnings per share (Diluted EPS) -21.32-0.12 — Average basic shares outstanding 1 00027.81 M — Diluted shares outstanding 1 00027.81 M — EBITDA —-4.04 M — EBIT —-4.18 M — Cost of revenue —19.89 M — Other cost of goods sold —— — Depreciation & amortization (cash flow) —138 K —